Friday, May 1, 2026

Understanding the Controversy: North Korea’s Uranium Enrichment and U.S. Relations Explained

Tensions rise in South Korea's National Assembly over Unification Minister Chung's remarks on North Korea's nuclear facilities amid U.S. scrutiny.

Musk Says AI Beats Humans This Year—Stanford Says No AGI in 2026: Who’s Right?

Scholars challenge claims of imminent AGI, predicting 2024 will focus on assessing AI's practical utility and productivity gains.

Russia Contacts South Korea Following North Korean Troop Withdrawal As Normalization Of Relations Nears Amid Speculation Of Post-War Shifts

Russia's informal talks with South Korea on North Korean issues reflect diplomatic sensitivity amid strained relations with Pyongyang.

Tag: pharmaceutical

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Discover How MobiCARE’s Wearable ECG Solution Detects Atrial Tachycardia Early

Daewoong Pharmaceutical's mobiCARE device detects atrial tachycardia early, enhancing cardiac health screenings for better patient outcomes.

Digital Health Week 2026: How Daewoong Pharmaceutical is Revolutionizing Healthcare with 8 Innovative Products

Daewoong Pharmaceutical's Digital Health Week 2026 showcased digital healthcare innovations to 39,753 professionals, highlighting real-world applications.

SK Chemicals’ Joins Tablet Surpasses 700 Billion KRW in Sales… What’s Behind the Osteoarthritis Drug’s Success?

SK Chemicals' Joins Tablets, a natural osteoarthritis treatment, surpasses 700 billion KRW in sales, marking a significant milestone in Korea.

Korea’s Olive Young Gets a New Sleep Aid: Daewon Launches Honey Sleep Shot Backed by a Study

Daewon Health launches Honey Sleep Shot, a plant-based sleep aid, in 900 Olive Young stores, targeting sleep issues for modern consumers.

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

Brivaracetam vs. Levetiracetam: Which Epilepsy Drug Offers Better Safety and Efficacy?

Samjin Pharmaceutical launches Bricetam Tablets, improving epilepsy treatment with fewer side effects and better adherence for patients.

A New Hair-Growth Pathway?: JW0061 Targets GFRA1 After 7.2x Organoid Results and a 39% Animal Boost

JW Pharmaceutical's hair loss treatment JW0061 gains FDA approval for clinical trials, promising innovative growth stimulation for men and women.

JW Pharmaceutical Advances Gout Treatment with Epaminurad

JW Pharmaceutical advances its gout treatment, Epaminurad, with global trials nearing completion and U.S. patent secured for market entry.

Unlocking Weight Loss: Hanmi Pharmaceutical’s Innovative H.O.P Project and the Game-Changing Epaglenatide

Hanmi Pharmaceutical is innovating obesity treatment with efpeglenatide and HM15275, focusing on tailored solutions for Korean patients.

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Unlocking Convenience: Rolvedon’s Same-Day Chemotherapy Solution for Neutropenia Revealed

Hanmi Pharmaceutical's Rolvedon shows potential for same-day chemotherapy administration, improving patient convenience and market competitiveness.

Chinese & Indian Medical Invasion: Pharmaceutic Dependency on Risk of Essential Medicine Supply

Concerns rise over South Korea's API industry reliance on China and India, with self-sufficiency at a record low of 25.6% in 2023.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.